Patent · US Expired

Treatment of anxiety with the aid of (S)-(-)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide

US5447952A · kind A · utility

13Cited by

3References

6Claims

0Family size

Assignee

UCB S.A. · BE

Inventors

Ernst Wulfert · Brussels, BE
Jean Gobert · Maisons-Alfort, FR
Alma Gower · Braine-l'Alleud, BE
Eric Cossement · Brussels, BE

Key dates

Filing date	Sep 20, 1994
Grant date	Sep 5, 1995
Priority date	—
Expiry date	Sep 20, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method is disclosed for the treatment of anxiety in a patient in need thereof, by administering to said patient an effective amount of (S)-(-)-.alpha.-ethyl-2-oxo-1-pyrrolidineacetamide of the formula ##STR1##

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.